表位
佐剂
免疫原性
肽疫苗
细胞毒性T细胞
免疫疗法
CD8型
免疫系统
T细胞
癌症免疫疗法
肽
癌症研究
病毒学
生物
免疫学
抗体
生物化学
体外
作者
Pengxiang Yang,Huijuan Song,Zujian Feng,Changrong Wang,Pingsheng Huang,Chuangnian Zhang,Deling Kong,Weiwei Wang
标识
DOI:10.1002/adtp.201900010
摘要
Abstract Peptide vaccines are used in clinical cancer immunotherapy, however, they generally suffer from suboptimal immunogenicity compared to live or inactive virus vector vaccines or subunit proteins, leading to limited T‐cell immune responses on their own. Here, a synthetic, supramolecular, and self‐adjuvanting CD8 + T‐cell epitope vaccine assembled by the peptide amphiphile conjugated with an epitope derived from tyrosinase‐related protein 2 is described. It is found that the obtained hydrogel vaccine on its own stimulates the activation of dendritic cells and elicits comparable therapeutic antitumor efficiency, but a clearly stronger endogenous CD8 + T‐cell response, compared with the vaccine comprised of peptide, adjuvant and delivery system, which is commonly used in clinic. In addition, combining this novel epitope vaccine with anti‐programmed cell death protein 1 (anti‐PD‐1) therapy significantly improves the therapeutic efficiency against melanoma. The supramolecular assembly approach and the self‐assembling peptide should undoubtedly enable a wide range of T‐cell epitope vaccines without the additional use of adjuvant and delivery system, and also provide new possibilities for therapeutic peptide delivery for cancer immunotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI